Substrate for nitric oxide synthesis NOS → endothelial NO → vasodilation. Intermediate in the urea cycle. Precursor to creatine (with glycine and methionine), polyamines (via ornithine), and proline. Oral F limited by saturable CAT-1 transport and first-pass hepatic arginase activity.
Oral (PO): Bioavailability (F): 68% · Volume of Distribution (Vd): 28 L · Absorption (ka): 1.5 h⁻¹ (t½ka ≈ 28m) [PMID 9833603]
Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 28 L [PMID 9833603]
Pathways It Modulates
Urea cycle (substrate) — urea cycle + NO precursor
Target Organ Systems
Cardiovascular System
digestive
Interactions
Lysine (caution): Arg and Lys compete for CAT-1 uptake; high-dose Arg promotes HSV reactivation whereas Lys suppresses it — opposing effects on herpes recurrence.
Agmatine (synergistic): Direct precursor via arginine decarboxylase.
Citrulline (synergistic): Citrulline bypasses arginase first-pass metabolism and is recycled to arginine — yielding higher and more sustained plasma arginine than oral arginine itself.